Showing results (101-110 of 107) with videos related to
Sort By:
Pageof 11
You have reached the last page of results.This site can display upto 107 results.
Theranostics|October 24, 2022
Synthesis, preclinical evaluation and radiation dosimetry of a dual targeting PET tracer [<sup>68</sup>Ga]Ga-FAPI-RGDJie Zang, Xuejun Wen, Rong Lin, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 23, 2022
A Paradigm of Cancer Immunotherapy Based on 2-[18F]FDG and Anti-PD-L1 mAb Combination to Enhance the Antitumor EffectXuejun Wen, Changrong Shi, Xinying Zeng, et al.Nature Nanotechnology|December 19, 2022
Targeting the activity of T cells by membrane surface redox regulation for cancer theranosticsChangrong Shi, Qianyu Zhang, Yuying Yao, et al.Journal of Medicinal Chemistry|May 26, 2026
Design and Evaluation of <sup>68</sup>Ga-Labeled Peptide-Based PET Probes for Noninvasive Imaging of ROR1 Expression in Tumor ModelsTao Yang, Qi An, Siying Lin, et al.Proceedings of the National Academy of Sciences of the United States of America|October 28, 2015
Virus-mimetic nanovesicles as a versatile antigen-delivery systemPengfei Zhang, Yixin Chen, Yun Zeng, et al.Acta Pharmaceutica Sinica. B|April 3, 2025
Safety, dosimetry, and efficacy of an optimized long-acting somatostatin analog for peptide receptor radionuclide therapy in metastatic neuroendocrine tumors: From preclinical testing to first-in-human studyWei Guo, Xuejun Wen, Yuhang Chen, et al.European Journal of Nuclear Medicine and Molecular Imaging|April 25, 2023
Development of [<sup>177</sup>Lu]Lu-LNC1003 for radioligand therapy of prostate cancer with a moderate level of PSMA expressionXuejun Wen, Pengfei Xu, Xinying Zeng, et al.Pageof 11